Sorry, you need to enable JavaScript to visit this website.
  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Living & Wellbeing Severe COVID-19 and the Continuing Importance of Protecting High Risk Populations The concept of "severe COVID-19" can be a frightening one. The term itself is so often misunderstood or confused with having severe symptoms of COVID. Programs & Initiatives The Future of Pharmacovigilance: Monitoring Medicine and Vaccine Safety Using AI and Other Tech Since 2014, Pfizer has used artificial intelligence to help sort through and categorize reports that people file when they experience an “adverse event.” Programs & Initiatives The Importance of Returning Clinical Trial Data to Participants Pfizer is providing participants with their own clinical trial data when an eligible trial ends via the Clinical Trial Participant Data Return Initiative.

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site